Abstract

Many diseases such as cancer are cured by natural substances, yet practical applications are limited by low pharmacodynamics due to poor solubility and permeability, photosensitivity, chemical instability, and first-pass metabolism. These issues are partly solved by nanotechnology. Here, we review briefly lipid-based nanomaterials for drug delivery. Indeed, lipid nanoconstructs allow active and passive targeting, biocompatibility, improved safety, and efficacy. Lipid nanoconstructs include both vesicular- and particulate-based systems such as liposomes, lipid micelles, solid lipid nanoparticles, and nanostructured lipid carriers.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.